Manufacturing · Growth Marketing
62%
Reduction in unqualified lead volume
How a Mid-Size Industrial Manufacturer Cut Unqualified Lead Volume by 62% and Moved Lead-to-Opportunity Conversion From 9% to 28%
A B2B industrial equipment manufacturer's paid search programme was generating volume with no connection to qualified pipeline. The problem was not the channel. It was a missing ICP definition and no attribution infrastructure connecting marketing spend to commercial outcomes.
Pharma · Conference Management
57%
Post-conference HCP action rate
Six Years of Annual Conferences. No Measurable Commercial Return. Here Is What Changed.
A specialty pharma organisation's annual medical conference had a compliance record it was proud of and attendance data it struggled to defend. The problem was not production quality. It was that the conference was not designed to produce commercial follow-through.
Pharma · Enterprise Technology
23% → 71%
SFA field adoption in 14 weeks
A Specialty Pharma Company Rebuilt Its SFA Program and Raised Field Adoption from 23% to 71% in 14 Weeks
A pharmaceutical field force of 180 representatives had completed an SFA implementation eighteen months prior. Adoption remained at 23%. The failure was not the platform. It was the conditions under which adoption was expected to happen.